Klea Holding SA

Klea Holding SA maintains a capital structure with a debt-to-equity ratio of 0.19, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 0.99, suggesting that its current liabilities are nearly equal to its current assets. The price-to-book ratio of 2.16 and the price-to-tangible-book ratio of 2.16 indicate that the market values the company's equity at a premium relative to its book value. In terms of profitability, Klea Holding SA reports a return on equity (ROE) of 8.26% and a return on assets (ROA) of 6.12%. These figures are below the industry median for ROE and ROA in the Healthcare Facilities & Services sector, suggesting that the company is generating returns that are in line with, but not significantly above, its peers. The company's net income of EUR 2,281,000 and operating income of EUR 3,622,000 reflect a healthy margin, but the gross profit margin of 96.0% is slightly below the industry median. Klea Holding SA's revenue is concentrated in the healthcare sector, particularly in the development and digitization of medical analysis centers. The company's Smart Salem network in the UAE and its Smart Health joint venture in Saudi Arabia are key contributors to its revenue. However, the company's geographic exposure is primarily in France and the Middle East, with no significant diversification into other regions. This concentration may expose the company to regional economic and regulatory risks. The company's growth trajectory is modest, with a revenue of EUR 22,166,000 in the latest reporting period. The outlook for the current fiscal year (FY) is for a slight increase in revenue, with a projected growth rate of less than 5%. The next FY is expected to show a similar growth pattern, with no significant acceleration in revenue growth. The company's capital expenditure of EUR -1,026,000 indicates a reduction in investment, which may affect its long-term growth potential. Klea Holding SA faces several risk factors, including a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could impact its ability to meet short-term obligations. The risk assessment also highlights the potential for dilution, although the probability is low. The company's valuation adjustments suggest that the market is pricing in a moderate level of risk, with a price-to-earnings ratio of 26.12 and an enterprise value-to-EBITDA ratio of 17.89. Recent events and filings indicate that Klea Holding SA has been focused on expanding its healthcare ventures in the Middle East. The company's Smart Salem network and Smart Health joint venture are key initiatives that have been highlighted in recent investor communications. The company has also been active in securing financing to support its growth strategy, with a long-term debt of EUR 5,225,000. The company's recent financial performance has been in line with analyst estimates, with a last actual EPS of EUR 0.00 and a last actual revenue of EUR 17,260,000.